Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Residual PH, persistent pulmonary hypertension after PEA"'
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 22, Iss, Pp 163-168 (2019)
International Journal of Cardiology. Heart & Vasculature
IJC Heart and Vasculature, 22, 163
International Journal of Cardiology. Heart & Vasculature
IJC Heart and Vasculature, 22, 163
Background: To improve clinical outcome, patients with inoperable and residual chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with riociguat. The aim of this study is to explore long-term outcomes and to compare our ‘real worl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5cbcb130269efb178d5ef206e47e83
https://dspace.library.uu.nl/handle/1874/385234
https://dspace.library.uu.nl/handle/1874/385234
Autor:
van Thor MCJ; Dept of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.; Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands., Ten Klooster L; Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands., Snijder RJ; Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands., Post MC; Dept of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands., Mager JJ; Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands.
Publikováno v:
International journal of cardiology. Heart & vasculature [Int J Cardiol Heart Vasc] 2019 Feb 28; Vol. 22, pp. 163-168. Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).
